How to Evaluate a Social Connection Referral Pathway Without a Research Team

Most social prescribing evaluations fail before they start, because someone designs a measurement plan that assumes a research team the programme doesn’t have. Then, six months in, nobody has the capacity to run it, the data is patchy, and the funder report is written from memory and a spreadsheet with holes in it. This is a design for the evaluation you can actually run with a link worker’s time and a shared drive.

The problem is not lack of evidence. It’s lack of the right evidence, collected consistently

The systematic reviews on social prescribing are consistent in one respect: individual studies report positive effects on things like self-esteem, self-confidence, and perceived wellbeing, but the evidence base is heterogeneous and short on controlled trials. A 2021 systematic review in the International Journal of Environmental Research and Public Health found self-esteem and confidence gains across included studies, alongside limited trial rigor. A separate review in Perspectives in Public Health found all nine included studies reported positive individual-level impacts, and three found reductions in GP, emergency, or inpatient service use — but nine studies is not a base you build causal claims on.

This means two things for your evaluation design. First, don’t promise a funder a mortality or cost-offset outcome you cannot demonstrate with the data you can realistically collect. Second, don’t skip measurement because the field’s evidence is uneven — that’s exactly the situation in which your own data becomes valuable, not less valuable.

Step 1: Separate isolation from loneliness before you pick a tool

The National Academies’ 2020 consensus report on older adults, and the clinical commentary that followed it in the American Journal of Geriatric Psychiatry, both push health systems toward routine assessment — but assessment of what, specifically, matters. Isolation (objective lack of contact) and loneliness (subjective distress about connection) are different constructs with different predictors and different responses to intervention. A 2024 study in Scientific Reports on isolation, age, and loneliness during the pandemic found the relationship between the two varies by age group — meaning a tool validated on one population may not travel to another.

Practically: decide up front whether your programme is trying to increase contact (isolation) or reduce distress about connection (loneliness). Most social prescribing referrals target isolation — get someone into a walking group, a men’s shed, a choir — but the outcome people actually feel and report on is loneliness. If you measure only attendance, you’ll show activity without showing whether it worked.

Step 2: Pick three measures, not fifteen

A minimum viable evaluation needs three things, collected the same way every time:

Measure	What it captures	How to collect it
A validated loneliness scale (short form)	Subjective distress, pre/post	Self-report at referral and at a fixed follow-up point, e.g. 12 weeks
Attendance/engagement count	Actual contact, objective	Logged by whoever runs the activity, not self-reported
One open-text question	What changed, in the person’s words	Asked at follow-up, coded later against a simple framework

Resist the temptation to add a wellbeing scale, a health service use tracker, and a social capital instrument on top of this. Every additional instrument is a point of drop-off. The qualitative meta-synthesis on social prescribing found that participants describe benefit extending beyond contact itself — restored purpose, meaningful participation — which is exactly what the open-text question is there to catch. A structured group activity with purpose tends to outperform contact alone, so your open-text coding should distinguish “I saw people” from “I had something to do that mattered.”

The follow-up gap is the failure mode to name

Call it the week-twelve vanishing: the referral is logged, the first session is attended, and then the record goes cold because nobody owns the follow-up measurement. This is not a data problem, it’s a staffing problem — collecting a follow-up loneliness score requires someone to actually ask, and link workers are not usually resourced for that as a discrete task. Build the follow-up contact into the referral itself: schedule it as an appointment, not an afterthought, and use the same channel (text, call, in-person) the person already responds to.

What this means in practice: before you write a single outcome into a funder proposal, confirm who will collect the twelve-week follow-up and what happens if they leave the post. If you can’t answer that, the evaluation will produce baseline data and nothing else — which tells you engagement but nothing about effect.

What a comparison group would buy you, and why you probably can’t afford one

The strongest available evidence for connection interventions in older adults comes from a randomised controlled trial — the HEAL-HOA study, which tested volunteering against a control group among lonely older adults in Hong Kong. That design is what lets researchers say an intervention caused a change, rather than that change happened alongside it. Almost no social prescribing programme has the resource to randomise referrals; withholding a service from a control arm is also often not ethically or operationally realistic in a live pathway. The honest workaround is a waiting-list comparison: if there is a natural delay between referral and first session, measure baseline loneliness at referral and again at the point activity starts, giving you a pre-intervention trend line to compare against the post-intervention one. It’s not a trial. It’s better than nothing, and it’s the ceiling of what most teams can run.

Evidence status, so you don’t oversell it

Claim	Evidence status
Social prescribing improves self-reported wellbeing and confidence	Supported by multiple reviews, but heterogeneous, mostly uncontrolled studies
Social prescribing reduces health service use	Reported in some included studies; not established as a general effect
Isolation and loneliness need separate measurement	Well supported by construct research
A specific social prescribing programme causes mortality reduction	Not established — do not claim this

What this does not solve

This design tells you whether people referred into your pathway got less lonely or more connected. It says nothing about who never got referred in the first place — the housebound, the undiagnosed, the people whose GP never raises it. The strongest social isolation risk, per the American Heart Association’s 2022 scientific statement, sits with people who are hardest to reach through a clinical referral in the first place. An evaluation of your pathway is not an evaluation of your reach.